References
- Steidl C, Connors JM, Gascoyne RD. Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment. J Clin Oncol 2011;29:1812–1826.
- Tan KL, Scott DW, Hong F, et al. Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial. Blood 2012;120:3280–3287
- Panico L, Ronconi F, Lepore M, et al. Prognostic role of tumor-associated macrophages and angiogenesis in classical Hodgkin lymphoma. Leuk Lymphoma 2013 Apr 11. [Epub ahead of print]
- Greaves P, Clear A, Coutinho R, et al. Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome. Clin Oncol 2013;31: 256–262.
- Rapisarda A, Melillo G. Role of the VEGF/VEGFR axis in cancer biology and therapy. Adv Cancer Res 2012;114:237–267.
- Paesler J, Gehrke I, Poll-Wolbeck SJ, et al. Targeting the vascular endothelial growth factor in hematologic malignancies. Eur J Haematol 2012;89:373–384.
- Dimtsas GS, Georgiadi EC, Karakitsos P, et al. Prognostic significance of immunohistochemical expression of the angiogenic molecules VEGF-A, VEGFR-1 and VEGFR-2 in patients with classical Hodgkin lymphoma. Leuk Lymphoma 2014;55:558–564.
- Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA 1990;263:1385–1389.